Valuation for LIMN - findataslice
 Liminatus Pharma, Inc.
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Jun-302025-Mar-31
Fiscal PeriodQ2-FY2025Q1-FY2025
Close Price of Common Stock1.58$1.65$11.16$
Market Cap of Common Stock42,626,797$42,924,144$290,323,304$
Market Cap of Common Stock QoQ%(.69%)(85.22%)
Market Cap of Common Stock YoY%
Common Shares Outstanding27,064,63326,014,63310017,500,00017,500,000100
Common Shares Outstanding QoQ%26,014,533.00%(100.00%)17,499,900.00%
Common Shares Outstanding YoY%54.66%48.66%.00%
Total Revenue TTM
Total Revenue
Total Revenue QoQ%
Total Revenue YoY%
Gross Margin
Earnings to Common Shareholders TTM
Earnings to Common Shareholders113,287$(327,526$)(961,207$)(1,753,978$)
Earnings to Common Shareholders QoQ%134.59%45.20%
Earnings to Common Shareholders YoY%111.79%81.33%
Profit Margin
Equity to Common Shareholders(8,807,412$)(19,667,589$)(19,340,063$)(18,508,939$)(17,547,732$)
Equity to Common Shareholders QoQ10,860,177$(327,526$)(961,207$)
Equity to Common Shareholders QoQ%55.22%(1.69%)(5.48%)
Equity to Common Shareholders YoY9,701,527$(2,119,857$)
Equity to Common Shareholders YoY%52.42%(12.08%)
Dividends Paid
Additional Paid-In Capital QoQ20,069,432$(9,323,393$)
Treasury Stock
Treasury Stock QoQ
Price to Sales
Price to Earnings
Price to Book---
Goodwill
Goodwill QoQ%
Goodwill YoY%
Other Intangible Assets
Other Intangible Assets QoQ
Amortization of Intangible Assets
Forward Price to Sales MRQ
Forward Price to Earnings MRQ94.07x94.72x640.68x
Total Assets1,908,781$5,408,859$
Total Assets QoQ
Total Assets YoY
Total Liabilities10,716,193$1,060$24,748,922$
Total Liabilities QoQ10,715,133$(24,747,862$)
Total Liabilities YoY
Current Ratio.17x.21x
Total Current Assets1,782,308$5,281,643$
Total Current Assets QoQ
Total Current Liabilities10,515,743$24,748,922$
Total Current Liabilities QoQ
Debt to Asset Ratio5.61x4.58x
Long Term Debt
Long Term Debt QoQ
Long Term Debt YoY
Capital Lease Obligations
Interest Expenses
Cash and Cash Equivalents
Cash and Cash Equivalents QoQ
Cash and Cash Equivalents YoY
Interest Income24,383$25,231$